Masahiro Hamanoue

1.1k total citations
30 papers, 893 citations indexed

About

Masahiro Hamanoue is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Masahiro Hamanoue has authored 30 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 11 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Masahiro Hamanoue's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Liver physiology and pathology (8 papers). Masahiro Hamanoue is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Liver physiology and pathology (8 papers). Masahiro Hamanoue collaborates with scholars based in Japan and United States. Masahiro Hamanoue's co-authors include Hisaaki Shimazu, Takashi Aikou, Kunio Matsumoto, Gen Tanabe, Yoshitada Ohi, Kenji Kadomatsu, Shuichiro Matsubara, Jun‐ichiro Tsutsui, Takao Senda and T. Muramatsu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Hepatology.

In The Last Decade

Masahiro Hamanoue

29 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahiro Hamanoue Japan 16 356 313 312 181 168 30 893
Saadia Faouzi France 9 386 1.1× 350 1.1× 141 0.5× 174 1.0× 109 0.6× 12 879
Koujiro Takase Japan 16 257 0.7× 494 1.6× 185 0.6× 260 1.4× 91 0.5× 35 961
Vivek Kohli United States 13 488 1.4× 265 0.8× 615 2.0× 244 1.3× 89 0.5× 19 1.0k
Melitta Penz-Österreicher United States 5 288 0.8× 256 0.8× 225 0.7× 233 1.3× 57 0.3× 6 773
ST Fan China 8 356 1.0× 273 0.9× 205 0.7× 163 0.9× 139 0.8× 10 799
Albert Geerts Belgium 13 458 1.3× 306 1.0× 200 0.6× 349 1.9× 65 0.4× 19 884
Mary Ann S. Crissey United States 14 196 0.6× 348 1.1× 242 0.8× 144 0.8× 48 0.3× 22 783
Véronique Neaud France 14 308 0.9× 304 1.0× 163 0.5× 110 0.6× 67 0.4× 29 807
Alicia M. Cole United Kingdom 10 264 0.7× 681 2.2× 257 0.8× 140 0.8× 97 0.6× 15 1.2k
Takuya Genda Japan 21 496 1.4× 494 1.6× 174 0.6× 383 2.1× 181 1.1× 68 1.2k

Countries citing papers authored by Masahiro Hamanoue

Since Specialization
Citations

This map shows the geographic impact of Masahiro Hamanoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Hamanoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Hamanoue more than expected).

Fields of papers citing papers by Masahiro Hamanoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Hamanoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Hamanoue. The network helps show where Masahiro Hamanoue may publish in the future.

Co-authorship network of co-authors of Masahiro Hamanoue

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Hamanoue. A scholar is included among the top collaborators of Masahiro Hamanoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Hamanoue. Masahiro Hamanoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamanoue, Masahiro, et al.. (2022). Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report. World Journal of Surgical Oncology. 20(1). 228–228. 13 indexed citations
2.
Arigami, Takaaki, Yusaku Osako, Masahiro Hamanoue, et al.. (2022). Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report. World Journal of Surgical Oncology. 20(1). 193–193. 6 indexed citations
3.
Matsushita, Daisuke, Yoshikazu Uenosono, Takaaki Arigami, et al.. (2021). Clinical significance of circulating tumor cells in the response to trastuzumab for HER2-negative metastatic gastric cancer. Cancer Chemotherapy and Pharmacology. 87(6). 789–797. 12 indexed citations
4.
Ando, Koji, Yasunori Emi, Masahiro Hamanoue, et al.. (2017). A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101). International Journal of Clinical Oncology. 22(5). 913–920. 6 indexed citations
5.
Aridome, Kuniaki, Kenji Baba, Masayuki Yanagi, et al.. (2015). A phase II, randomized study of aprepitant in the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapies in colorectal cancer patients. Molecular and Clinical Oncology. 4(3). 393–398. 15 indexed citations
6.
Baba, Yasutaka, Kazuto Ueno, Masayuki Nakajo, et al.. (2010). Comparison of survival rates between patients treated with transcatheter arterial chemoembolization and hepatic resection for solitary hepatocellular carcinoma. Oncology Letters. 1(5). 905–911. 4 indexed citations
7.
Nakajo, Akihiro, Shuichi Hokita, Sumiya Ishigami, et al.. (2008). A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer. Cancer Chemotherapy and Pharmacology. 62(6). 1103–1109. 21 indexed citations
8.
Hiwatashi, Kiyokazu, Shinichi Ueno, Kazuhiro Abeyama, et al.. (2007). A Novel Function of the Receptor for Advanced Glycation End-Products (RAGE) in Association with Tumorigenesis and Tumor Differentiation of HCC. Annals of Surgical Oncology. 15(3). 923–933. 68 indexed citations
9.
Tanabe, Gen, et al.. (2001). Favorable quality of life after repeat hepatic resection for recurrent hepatocellular carcinoma.. PubMed. 48(38). 506–10. 18 indexed citations
10.
Fukukura, Yoshihiko, Masahiro Hamanoue, Fumito Fujiyoshi, et al.. (2000). Cholangiolocellular Carcinoma of the Liver: CT and MR Findings. Journal of Computer Assisted Tomography. 24(5). 809–812. 40 indexed citations
11.
12.
Ueno, Shuichi, et al.. (1997). Serum hepatocyte growth factor (HGF) levels predict the outcomes in hepatectomized patients with postoperative hyperbilirubinemia. International Hepatology Communications. 6(6). 294–299. 4 indexed citations
13.
Tanabe, Gen, Takashi Aikou, Masahiro Hamanoue, et al.. (1996). High serum alpha-fetoprotein concentration associated with pseudoinfarction of a cirrhotic liver: Report of a case. Surgery Today. 26(10). 818–821. 4 indexed citations
14.
Kobayashi, Yasuyuki, Masahiro Hamanoue, Takashi Aikou, et al.. (1996). Induction of Hepatocyte Growth by Intraportal Infusion of HGF into Beagle Dogs. Biochemical and Biophysical Research Communications. 220(1). 7–12. 18 indexed citations
15.
Ueno, Shinichi, Takashi Aikou, Gen Tanabe, et al.. (1996). Exogenous hepatocyte growth factor markedly stimulates liver regeneration following portal branch ligation in dogs. Cancer Chemotherapy and Pharmacology. 38(3). 233–237. 21 indexed citations
16.
Hamanoue, Masahiro, et al.. (1995). Expression of HGF and TGF-?1 mRNA after partial hepatectomy in rats with liver cirrhosis. Surgery Today. 25(3). 237–243. 18 indexed citations
17.
Kawaida, Kouichi, Gen Tanabe, Masahiro Hamanoue, et al.. (1993). Indication and Effect of Hemopurification for Hyperbilirubinemia after Hepatectomy for Hepatocellular Carcinoma.. The Japanese Journal of Gastroenterological Surgery. 26(5). 1227–1232. 2 indexed citations
18.
Miyauchi, Teruo, Masahiro Hamanoue, Shinji Ando, et al.. (1992). A Novel Core Protein as Well as Polymorphic Epithelial Mucin Carry Peanut Agglutinin Binding Sites in Human Gastric Carcinoma Cells: Sequence Analysis and Examination of Gene Expression1. The Journal of Biochemistry. 112(5). 609–615. 38 indexed citations
19.
Hamanoue, Masahiro, Kouichi Kawaida, Sonshin Takao, et al.. (1992). Rapid and Marked Induction of Hepatocyte Growth Factor During Liver Regeneration After Ischemic or Crush Injury. Hepatology. 16(6). 1485–1492. 65 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saadia Faouzi Breakdown of academic impact, for papers by Koujiro Takase Breakdown of academic impact, for papers by Vivek Kohli Breakdown of academic impact, for papers by Melitta Penz-Österreicher Breakdown of academic impact, for papers by ST Fan Breakdown of academic impact, for papers by Albert Geerts Breakdown of academic impact, for papers by Mary Ann S. Crissey Breakdown of academic impact, for papers by Véronique Neaud Breakdown of academic impact, for papers by Alicia M. Cole Breakdown of academic impact, for papers by Takuya Genda
Rankless by CCL
2026